i-SENS Inc (099190) - Total Assets
Based on the latest financial reports, i-SENS Inc (099190) holds total assets worth ₩591.04 Billion KRW (≈ $400.54 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check i-SENS Inc (099190) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
i-SENS Inc - Total Assets Trend (2012–2025)
This chart illustrates how i-SENS Inc's total assets have evolved over time, based on quarterly financial data. Explore 099190 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
i-SENS Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
i-SENS Inc's total assets of ₩591.04 Billion consist of 44.7% current assets and 55.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 7.8% |
| Accounts Receivable | ₩67.32 Billion | 11.7% |
| Inventory | ₩74.48 Billion | 12.9% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩20.60 Billion | 3.6% |
| Goodwill | ₩12.17 Billion | 2.1% |
Asset Composition Trend (2012–2025)
This chart illustrates how i-SENS Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 099190 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: i-SENS Inc's current assets represent 44.7% of total assets in 2025, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 7.8% of total assets in 2025, up from 1.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 1.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 12.9% of total assets.
i-SENS Inc Competitors by Total Assets
Key competitors of i-SENS Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Elbit Med Tech
TA:EMTC
|
Israel | ILA25.53 Million |
|
InBody Co.Ltd
KQ:041830
|
Korea | ₩318.34 Billion |
|
Value Added Technology Co. Ltd
KQ:043150
|
Korea | ₩658.61 Billion |
|
INFINITT Healthcare Co. Ltd
KQ:071200
|
Korea | ₩229.14 Billion |
|
MEDIANA Co.Ltd
KQ:041920
|
Korea | ₩147.44 Billion |
|
Sewoon Medical Co. Ltd
KQ:100700
|
Korea | ₩167.34 Billion |
|
Meta Biomed Co. Ltd
KQ:059210
|
Korea | ₩180.11 Billion |
|
CU Medical Systems Inc
KQ:115480
|
Korea | ₩99.66 Billion |
i-SENS Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 2.50 | 4.89 |
| Quick Ratio | 1.20 | 1.80 | 3.74 |
| Cash Ratio | 0.00 | 0.00 | 1.38 |
| Working Capital | ₩111.79 Billion | ₩157.90 Billion | ₩139.75 Billion |
i-SENS Inc - Advanced Valuation Insights
This section examines the relationship between i-SENS Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.37 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -2.2% |
| Total Assets | ₩577.66 Billion |
| Market Capitalization | $150.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values i-SENS Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: i-SENS Inc's assets decreased by 2.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for i-SENS Inc (2012–2025)
The table below shows the annual total assets of i-SENS Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩577.66 Billion ≈ $391.47 Million |
-2.23% |
| 2024-12-31 | ₩590.87 Billion ≈ $400.42 Million |
+18.45% |
| 2023-12-31 | ₩498.82 Billion ≈ $338.04 Million |
+10.95% |
| 2022-12-31 | ₩449.57 Billion ≈ $304.67 Million |
+4.75% |
| 2021-12-31 | ₩429.18 Billion ≈ $290.85 Million |
+39.78% |
| 2020-12-31 | ₩307.03 Billion ≈ $208.07 Million |
+13.70% |
| 2019-12-31 | ₩270.04 Billion ≈ $183.00 Million |
+7.14% |
| 2018-12-31 | ₩252.05 Billion ≈ $170.81 Million |
+7.68% |
| 2017-12-31 | ₩234.08 Billion ≈ $158.63 Million |
+8.84% |
| 2016-12-31 | ₩215.07 Billion ≈ $145.75 Million |
+19.61% |
| 2015-12-31 | ₩179.80 Billion ≈ $121.85 Million |
+9.96% |
| 2014-12-31 | ₩163.51 Billion ≈ $110.81 Million |
+15.62% |
| 2013-12-31 | ₩141.41 Billion ≈ $95.83 Million |
+53.63% |
| 2012-12-31 | ₩92.05 Billion ≈ $62.38 Million |
-- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more